RankingsPricing
  1. US-listed companies
  2. CASSAVA SCIENCES INC

CASSAVA SCIENCES INCSAVA

Market cap
$1.2B
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023
Research and development, net of grant reimbursement88579983----89
Research and development, net of grant reimbursement--------232568-
General and administrative775556443481217
General and administrative775556443481217
Total operating expenses151510121415127563380106
Gain on sale of property and equipment---------0---
Operating loss-4-431-12-14-15-12-7-5-6-33-80-106
Total operating expenses151510121415127563380106
Interest income------------8
Other income, net----------011
Net loss-3-332-12-14-15-12-7-5-6-32-76-97
Net loss per share, basic and diluted (in dollars per share)--0.7-0.27-0.31--------2.32
Research and development, net of grant reimbursement88579983----89
Research and development, net of grant reimbursement--------232568-
General and administrative775556443481217
General and administrative775556443481217
Total operating expenses151510121415127563380106
Gain on sale of property and equipment---------0---
Operating loss-4-431-12-14-15-12-7-5-6-33-80-106
Total operating expenses151510121415127563380106
Interest income------------8
Other income, net----------011
Net loss-3-332-12-14-15-12-7-5-6-32-76-97
Net loss per share, basic and diluted (in dollars per share)--0.7-0.27-0.31--------2.32
Operating loss-4-431-12-14-15-12-7-5-6-33-80-106
Interest income100000000003-
Other income, net----------011
Net loss-3-332-12-14-15-12-7-5-6-32-76-97
Net loss per share, basic and diluted------------1.9-